Biologics

MedImmune will create a standalone company for early-stage inflammatory and autoimmunity biologics.

Surgeons attending the American Academy of Orthopaedic Surgeons 2018 Annual Meeting in New Orleans March 6 to 10 can expect to discuss biologics and opioids, according to Medscape.

Researchers grafted human spinal cord-derived neural progenitor cells into cervical spinal cord injury sites in rhesus monkeys in a study in Nature Medicine. The human stem cells matured into nerve cells in the monkeys, spurring neuronal connections and improving the monkeys'…

Researchers at the New York Genome Center and New York University in New York City developed a 3-D printed, portable and low-cost microfluidic device to facilitate access to single-cell sequencing. The researchers used the device to study synovial tissue from…

Bioventus will co-develop a next generation bone allograft solution for spine and trauma surgery with Tampa, Fla.-based LifeLink Tissue Bank.

Johnson & Johnson is collaborating with Advanced Materials and BioEngineering Research to establish a 3-D bioprinting laboratory. Work on the new laboratory will begin in the first quarter of 2018.

The first patient in Centrexion Therapeutics Corp.'s Phase 3 VICTORY-1 clinical trial has been dosed with CNTX-4975, a synthetic trans-capsaicin injection for the treatment of chronic moderate to severe pain due to knee osteoarthritis.

Bone Therapeutics finished patient recruitment for its Phase IIA lumbar spinal fusion study.

Houston-based regenerative medicine company SpinalCyte completed the first double-blind, placebo-controlled human trial using CybroCell, a human dermal fibroblast injection to treat degenerative disc disease.

Stempeutics Research signed an outlicensing deal with Alkem Laboratories for the knee osteoarthritis therapy Stempeucel, according to Business Today.